Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Hirose

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Medical Investigation : JMI|December 22, 2005
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonistTsuyoshi Hirose, Tetsuro Kikuchi
The Journal of Endocrinology|April 16, 2010
Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptanToshiki Miyazaki, Koji Ohmoto, Tsuyoshi Hirose, et al.
The International Journal of Neuroscience|November 29, 2007
The effect of aripiprazole on prepulse inhibition of the startle response in normal and hyperdopaminergic states in ratsSatoru Nakai, Tsuyoshi Hirose, Toyoki Mori, et al.
Neuropsychopharmacology Reports|May 7, 2021
Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazoleTetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, et al.
Neuropsychopharmacology Reports|January 17, 2023
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in miceNaoki Amada, Tsuyoshi Hirose, Mikio Suzuki, et al.
Journal of Pharmacological Sciences|March 8, 2007
Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidineKenji Maeda, Haruhiko Sugino, Tsuyoshi Hirose, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profileTsuyoshi Hirose, Yasufumi Uwahodo, Sakiko Yamada, et al.
European Journal of Pharmacology|July 16, 2003
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidoneSatoru Nakai, Tsuyoshi Hirose, Yasufumi Uwahodo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Medical Investigation : JMI|December 22, 2005
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonistTsuyoshi Hirose, Tetsuro Kikuchi
The Journal of Endocrinology|April 16, 2010
Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptanToshiki Miyazaki, Koji Ohmoto, Tsuyoshi Hirose, et al.
The International Journal of Neuroscience|November 29, 2007
The effect of aripiprazole on prepulse inhibition of the startle response in normal and hyperdopaminergic states in ratsSatoru Nakai, Tsuyoshi Hirose, Toyoki Mori, et al.
Neuropsychopharmacology Reports|May 7, 2021
Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazoleTetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, et al.
Neuropsychopharmacology Reports|January 17, 2023
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in miceNaoki Amada, Tsuyoshi Hirose, Mikio Suzuki, et al.
Journal of Pharmacological Sciences|March 8, 2007
Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidineKenji Maeda, Haruhiko Sugino, Tsuyoshi Hirose, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profileTsuyoshi Hirose, Yasufumi Uwahodo, Sakiko Yamada, et al.
European Journal of Pharmacology|July 16, 2003
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidoneSatoru Nakai, Tsuyoshi Hirose, Yasufumi Uwahodo, et al.
Pageof 1